Advertisement

Protocols for in vitro Differentiation of Human Mesenchymal Stem Cells into Osteogenic, Chondrogenic and Adipogenic Lineages

  • Maria Chiara Ciuffreda
  • Giuseppe Malpasso
  • Paola Musarò
  • Valentina Turco
  • Massimiliano GnecchiEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1416)

Abstract

Mesenchymal stem cells (MSC) possess high plasticity and the potential to differentiate into several different cell types; this characteristic has implications for cell therapy and reparative biotechnologies. MSC have been originally isolated from the bone marrow (BM-MSC), but they have been found also in other tissues such as adipose tissue, cord blood, synovium, skeletal muscle, and lung. MSC are able to differentiate in vitro and in vivo into several cell types such as bone, osteocytes, chondrocytes, adipocytes, and skeletal myocytes, just to name a few.

During the last two decades, an increasing number of studies have proven the therapeutic potential of MSC for the treatment of neurodegenerative diseases, spinal cord and brain injuries, cardiovascular diseases, diabetes mellitus, and diseases of the skeleton. Their immuno-privileged profile allows both autologous and allogeneic use. For all these reasons, the scientific appeal of MSC is constantly on the rise.

The identity of MSC is currently based on three main criteria: plastic-adherence capacity, defined epitope profile, and capacity to differentiate in vitro into osteocytes, chondrocytes, and adipocytes. Here, we describe standard protocols for the differentiation of BM-MSC into the osteogenic, chondrogenic, and adipogenic lineages.

Key words

Mesenchymal stem cells Bone marrow Adipocytes Chondrocytes Osteocytes 

References

  1. 1.
    Cohnheim JF (1867) Über Entzündung und Eiturung. Path Anat Physiol Klin Med 40:1–79Google Scholar
  2. 2.
    Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16:381–390PubMedGoogle Scholar
  3. 3.
    Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403PubMedGoogle Scholar
  4. 4.
    Friedenstein AJ, Deriglasova UF, Kulagina NN et al (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83–92PubMedGoogle Scholar
  5. 5.
    Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147CrossRefPubMedGoogle Scholar
  6. 6.
    Jaiswal N, Haynesworth SE, Caplan AI et al (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295–312CrossRefPubMedGoogle Scholar
  7. 7.
    Johnstone B, Hering TM, Caplan AI et al (1998) In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265–272CrossRefPubMedGoogle Scholar
  8. 8.
    Wakitani S, Saito T, Caplan AI (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417–1426CrossRefPubMedGoogle Scholar
  9. 9.
    Digirolamo CM, Stokes D, Colter D et al (1999) Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275–281CrossRefPubMedGoogle Scholar
  10. 10.
    De Bari C, Dell'Accio F, Tylzanowski P et al (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928–1942CrossRefPubMedGoogle Scholar
  11. 11.
    Sabatini F, Petecchia L, Tavian M et al (2005) Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 85:962–971CrossRefPubMedGoogle Scholar
  12. 12.
    Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al (2000) Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2:477–488CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Baer PC, Geiger H (2012) Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int 2012:812693CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249–1260CrossRefPubMedGoogle Scholar
  15. 15.
    Gnecchi M, Danieli P, Cervio E (2012) Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 57:48–55CrossRefPubMedGoogle Scholar
  16. 16.
    Horwitz EM, Le Blanc K, Dominici M et al (2005) Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 7:393–395CrossRefPubMedGoogle Scholar
  17. 17.
    Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317CrossRefPubMedGoogle Scholar
  18. 18.
    Baksh D, Yao R, Tuan RS (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384–1392CrossRefPubMedGoogle Scholar
  19. 19.
    Bosnakovski D, Mizuno M, Kim G et al (2005) Isolation and multilineage differentiation of bovine bone marrow mesenchymal stem cells. Cell Tissue Res 319:243–253CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Maria Chiara Ciuffreda
    • 1
    • 2
    • 3
  • Giuseppe Malpasso
    • 1
    • 2
    • 3
  • Paola Musarò
    • 2
    • 3
  • Valentina Turco
    • 2
    • 3
  • Massimiliano Gnecchi
    • 1
    • 2
    • 3
    • 4
    Email author
  1. 1.Department of Molecular Medicine, Unit of CardiologyUniversity of PaviaPaviaItaly
  2. 2.Department of Cardiothoracic and Vascular Sciences – Coronary Care Unit and Laboratory of Clinical and Experimental CardiologyFondazione IRCCS Policlinico San MatteoPaviaItaly
  3. 3.Laboratory of Experimental Cardiology for Cell and Molecular TherapyFondazione IRCCS Policlinico San MatteoPaviaItaly
  4. 4.Department of MedicineUniversity of Cape TownCape TownSouth Africa

Personalised recommendations